Mallinckrodt, a subsidiary of Covidien of Hamilton, Bermuda, has filed suit against two U.S.-based subsidiaries of Italian contrast firm Bracco for patent infringement, according to the St. Louis Business Journal.
The suit, filed in Delaware federal court, claims that Bracco has infringed upon a patent for a device used to inject contrast into patients undergoing MRI. Mallinckrodt of Hazelwood, MO, is seeking damages, a jury trial, and an injunction to prevent infringement by Bracco's E-Z-EM unit of Lake Success, NY, and Acist Medical Systems of Eden Prairie, MN, the Journal reported.
Related Reading
Covidien, B&W to tackle medical isotope dilemma, January 28, 2009
Covidien and B&W to develop isotope technology, January 26, 2009
Covidien to move HQ to Ireland, January 7, 2009
Covidien shows gains in fiscal 2008, November 17, 2008
PETNet, Covidien join forces, November 3, 2008
Copyright © 2009 AuntMinnie.com
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=100&w=100&auto=format%2Ccompress&q=70)
.fFmgij6Hin.png?crop=focalpoint&fit=crop&fp-x=0.5&fp-y=0.5&h=167&w=250&auto=format%2Ccompress&q=70)
